Form 4: ResMed CFO Brett Sandercock Sells 1,000 Shares
SEC Filing
ResMed's Chief Financial Officer, Brett Sandercock, sold 1,000 shares of ResMed common stock at a price of $233.47 on October 8, 2024, according to a Form 4 filing with the SEC.
Summary
- On October 8, 2024, Brett Sandercock, the Chief Financial Officer of ResMed Inc., sold 1,000 shares of ResMed common stock.
- The sale was executed at a price of $233.47 per share.
- Following the transaction, Sandercock directly owns 95,812 shares of ResMed common stock.
- The transaction was conducted under a Rule 10b5-1 plan adopted on February 6, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine transaction under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Sales by company insiders are a common occurrence and are often related to personal financial planning. The market typically analyzes the size and frequency of insider transactions to gauge sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/06/2024 | Date of adoption of Rule 10b5-1 plan |
| 10/08/2024 | Date of transaction (sale of shares) |
| 10/09/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.